Researcher Database

（Last updated : 2024-04-27 15:35:24）

KANEYASU TAKAKO

Department / Course College of Life Sciences Department of Biomedical Sciences

Title / Position Assistant Professor

Achievement
- Other Affiliations
Profile
research
teaching
- Subject
- Teaching achievements
social activity
- Activity in society
- Research exchange preferred theme
Others

Academic background
1.	～2020/03	Doctorial Course │ Doctor’s Program in Medical and Biopharmaceutical Science │ Graduate School of Pharmacy │ International University of Health and Welfare │ Completed
2.	～2016/03	Master Course │ Master’s Program in Biopharmaceutical Science │ Graduate School of Pharmaceutical Science │ International University of Health and Welfare │ Completed
3.	～2011/09	Faculty of Economics │ Keio University (Correspondence School) │ Graduated
4.	～1990/03	Pharmaceutical Chemistry │ Faculty of Pharmacy │ Meiji Pharmaceutical University │ Graduated

Academic background

～2020/03

Doctorial Course │ Doctor’s Program in Medical and Biopharmaceutical Science │ Graduate School of Pharmacy │ International University of Health and Welfare │ Completed

～2016/03

Master Course │ Master’s Program in Biopharmaceutical Science │ Graduate School of Pharmaceutical Science │ International University of Health and Welfare │ Completed

～2011/09

Faculty of Economics │ Keio University (Correspondence School) │ Graduated

～1990/03

Pharmaceutical Chemistry │ Faculty of Pharmacy │ Meiji Pharmaceutical University │ Graduated

Research activities
1.		Health Technology Assessment International
2.		International Society for Pharmacoeconomics and Outcome Research
3.		International Society for Quality of Life Research
4.		Japanese Society for QOL-PRO research
5.		the Asian Association for the Study of Diabetes
Display All（6）

Research activities

Health Technology Assessment International

International Society for Pharmacoeconomics and Outcome Research

International Society for Quality of Life Research

Japanese Society for QOL-PRO research

the Asian Association for the Study of Diabetes

Display All（6）

Qualification and license
1.	1990	the pharmacist license in Japan

Qualification and license

1990

the pharmacist license in Japan

Subject of research
1.	Research on cost-effectiveness and patient-reported outcomes of drugs and other products

Subject of research

Research on cost-effectiveness and patient-reported outcomes of drugs and other products

Research summary
Cost-effectiveness of drugs and others Patient-reported outcomes Patient public involvement

Research summary

Cost-effectiveness of drugs and others
Patient-reported outcomes
Patient public involvement

Papers
1.	2024/03/13	How to select and understand guidelines for patient-reported outcomes: a scoping review of existing guidance │ BMC Health Serv Res │ 24 (1),pp.334 (Co-authored)
2.	2024/01/19	Perceptions regarding the concept and definition of patient-reported outcomes among healthcare stakeholders in Japan with relation to quality of life: a cross-sectional study │ Health Qual Life Outcomes │ 22 (8) (Co-authored)
3.	2023/01	[Translation into Japanese] Mapping to Estimate Health-State Utility from Non– Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report │ Jpn Pharmacol Ther │ 51 (1),pp.31-45 (Co-authored)
4.	2022/08	[Translation into Japanese] Clinician's checklist for reading and using an article about patient-reported outcomes │ Jpn Pharmacol Ther │ 50 (8),pp.1317-1326 (Co-authored)
5.	2019/12	Cost effectiveness Analysis of Early Intervention with Insulin for Patients with Type 2 Diabetes Mellitus in Japan │ ,pp.268-282 (Co-authored)

Papers

2024/03/13

How to select and understand guidelines for patient-reported outcomes: a scoping review of existing guidance │ BMC Health Serv Res │ 24 (1),pp.334 (Co-authored)

2024/01/19

Perceptions regarding the concept and definition of patient-reported outcomes among healthcare stakeholders in Japan with relation to quality of life: a cross-sectional study │ Health Qual Life Outcomes │ 22 (8) (Co-authored)

2023/01

[Translation into Japanese] Mapping to Estimate Health-State Utility from Non– Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report │ Jpn Pharmacol Ther │ 51 (1),pp.31-45 (Co-authored)

2022/08

[Translation into Japanese] Clinician's checklist for reading and using an article about patient-reported outcomes │ Jpn Pharmacol Ther │ 50 (8),pp.1317-1326 (Co-authored)

2019/12

Cost effectiveness Analysis of Early Intervention with Insulin for Patients with Type 2 Diabetes Mellitus in Japan │ ,pp.268-282 (Co-authored)

Message
1.	Developing the reliable and convincing health care systems Universal health coverage system in Japan has been facing financial crisis because of aging society. How we can overcome this situation? Fairness, equity, and efficiency in fields of medical treatment that are key to resolving issues.　 Why don’t you think about the sustainability of health care system with us？

Message

Developing the reliable and convincing health care systems
Universal health coverage system in Japan has been facing financial crisis because of aging society. How we can overcome this situation?
Fairness, equity, and efficiency in fields of medical treatment that are key to resolving issues.　
Why don’t you think about the sustainability of health care system with us？

E-Mail Address